Dipyridamole for Immune Activation in HIV

NCT02121756 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Dipyridamole
DRUG: Placebo, then Dipyridamole

Sponsor

Sharon Riddler

Collaborators

[object Object]